×
ADVERTISEMENT

asthma

Dashboard Shortens Therapy Gaps And Speeds Medication Delivery

Specialty pharmacists at Vanderbilt Health built user-friendly dashboards that have improved the speed of coverage ...

JUNE 15, 2025

4 Ways AI Could Ease Resource Challenges in Small and Rural Hospitals

AI could alleviate access and resource challenges in small and rural hospitals by streamlining administrative ...

JANUARY 17, 2025

Biologics Hit Multiple Targets in Asthma and COPD

The future of pulmonary medicine is rapidly evolving, with biologic therapies hitting multiple targets in asthma ...

OCTOBER 28, 2024

Using Data-Driven Monitoring Tools Boosts SP Outcomes

Vanderbilt Specialty Pharmacy has harnessed the power of patient monitoring tools to manage IBD, asthma and other ...

OCTOBER 14, 2023

FDA Grants New Indication for Tezspire for Self-Administration

The monoclonal antibody Tezspire received a new indication to allow self-administration in a prefilled, single-use ...

FEBRUARY 3, 2023

Dupixent Reduces Asthma Exacerbations in Younger Children

Young children—6 to 11 years old—saw significantly reduced exacerbations with Dupixent, according to ...

MAY 19, 2021

Dupixent Appears to Reduce Severe Asthma Exacerbations in Children

In the United States, there are approximately 75,000 children aged 6 to 11 years with uncontrolled moderate to ...

OCTOBER 14, 2020

Asthma/COPD Patients in PAPs Had Fewer Hospital Visits

Patients with asthma and chronic obstructive pulmonary disease (COPD) enrolled in patient assistance programs ...

JULY 9, 2020

FDA Approves New Indication for Dupixent for Asthma

Dupilumab inhibits the overactive signaling of IL-4 and IL-13, two key proteins that contribute to the Type 2 ...

OCTOBER 20, 2018

Load more